Anemia in a cohort of men with macroprolactinomas: Increase in hemoglobin levels follows prolactin suppression

Pituitary

Volumn 14, Issue 1, 2011, Pages 11-15

  Shimon, Ilan ^a,b   Benbassat, Carlos ^a,b   Tzvetov, Gloria ^a,b   Grozinsky Glasberg, Simona ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anemia; Cabergoline; Hemoglobin; Hypogonadism; Prolactinoma; Testosterone

Indexed keywords

CABERGOLINE; HEMOGLOBIN; PROLACTIN; TESTOSTERONE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOPHYSIS APOPLEXY; LIQUORRHEA; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TESTOSTERONE BLOOD LEVEL; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; ERGOLINES; HEMOGLOBINS; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; PROLACTIN; PROLACTINOMA; RETROSPECTIVE STUDIES; TESTOSTERONE;

EID: 79951953556     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-010-0251-6     Document Type: Article

References (24)

1. A Colao A Di Sarno P Cappabianca F Briganti R Pivonello CD Somma A Faggiano B Biondi G Lombardi 2003 Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia Eur J Endocrinol 148 325 331 1:CAS:528:DC%2BD3sXis1amtL8%3D 10.1530/eje.0.1480325 12611613 (Pubitemid 36410718)
2. A Klibanski 2010 Clinical practice. Prolactinomas N Engl J Med 362 1219 1226 1:CAS:528:DC%2BC3cXkt1egsr4%3D 10.1056/NEJMcp0912025 20357284
3. RD Calle-Rodrigue C Giannini BW Scheithauer RV Lloyd PC Wollan KT Kovacs L Stefaneanu AB Ebright CF Abboud DH Davis 1998 Prolactinomas in male and female patients: a comparative clinicopathologic study Mayo Clin Proc 73 1046 1052 1:STN:280:DyaK1M%2FjsFeqtQ%3D%3D 10.4065/73.11.1046 9818037 (Pubitemid 28512579)
4. E Delgrange J Trouillas D Maiter J Donckier J Tourniaire 1997 Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study J Clin Endocrinol Metab 82 2102 2107 1:CAS:528:DyaK2sXksVCnsro%3D 10.1210/jc.82.7.2102 9215279 (Pubitemid 27287568)
5. H Nishioka J Haraoka K Akada S Azuma 2002 Gender-related differences in prolactin secretion in pituitary prolactinomas Neuroradiology 44 407 410 1:STN:280:DC%2BD383nt1CnsA%3D%3D 10.1007/s00234-002-0774-2 12012125 (Pubitemid 36097191)
6. H Nishioka J Haraoka K Akada 2003 Growth potential of prolactinomas in men: is it really different from women? Surg Neurol 59 386 390 10.1016/S0090-3019(03)00012-0 12765811 (Pubitemid 36583605)
7. JP Walsh PT Pullan 1997 Hyperprolactinaemia in males: a heterogeneous disorder Aust N Z J Med 27 385 390 1:STN:280:DyaK1c7htVemtA%3D%3D 9448878 (Pubitemid 27404842)
8. JJ Pinzone L Katznelson DC Danila DK Pauler CS Miller A Klibanski 2000 Primary medical therapy of micro- and macroprolactinomas in men J Clin Endocrinol Metab 85 3053 3057 1:CAS:528:DC%2BD3cXmsVKruro%3D 10.1210/jc.85.9.3053 10999785
9. MP Gillman ME Molitch G Lombardi A Colao 2006 Advances in the treatment of prolactinomas Endocr Rev 27 485 534 10.1210/er.2005-9998 (Pubitemid 44213229)
10. A Colao G Vitale P Cappabianca F Briganti A Ciccarelli M De Rosa S Zarrilli G Lombardo 2004 Outcome of cabergoline treatment in men with prolactinoma: effect of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis J Clin Endocrinol Metab 89 1704 1711 1:CAS:528:DC%2BD2cXjt1elsbc%3D 10.1210/jc.2003-030979 15070934 (Pubitemid 38507923)
11. I Shimon C Benbassat M Hadani 2007 Effectiveness of long-term cabergoline treatment for giant prolactinomas: study of 12 men Eur J Endocrinol 156 225 231 1:CAS:528:DC%2BD2sXntlyqu7Y%3D 10.1530/EJE-06-0646 17287412 (Pubitemid 46554517)
12. AL Hulting C Muhr PO Lundberg S Werner 1985 Prolactinomas in men: clinical characteristics and the effect of bromocriptine treatment Acta Med Scand 217 101 109 1:STN:280:DyaL2M7ksFWktQ%3D%3D 10.1111/j.0954-6820.1985. tb01642.x 3919529 (Pubitemid 15128929)
13. DB Ellegala TD Alden DE Couture ML Vance NF Maartens ER Laws Jr 2003 Anemia, testosterone, and pituitary adenoma in men J Neurosurg 98 974 977 10.3171/jns.2003.98.5.0974 12744356 (Pubitemid 36460887)
14. L Ferrucci M Maggio S Bandinelli S Basaria F Lauretani A Ble G Valenti WBM Ershler JM Guralnik DL Longo 2006 Low testosterone levels and the risk of anemia in older men and women Arch Intern Med 166 1380 1388 1:CAS:528: DC%2BD28Xns1Crsbs%3D 10.1001/archinte.166.13.1380 16832003 (Pubitemid 44036350)
15. AP Gold AF Michael Jr 1959 Congenital adrenal hyperplasia associated with polycythemia Pediatrics 23 727 730 1:STN:280:DyaG1M%2FnsVOisA%3D%3D 13645107
16. EL Rhoden A Morgentaler 2004 Risks of testosterone-replacement therapy and recommendations for monitoring N Engl J Med 350 482 492 1:CAS:528: DC%2BD2cXos1Wjsw%3D%3D 10.1056/NEJMra022251 14749457 (Pubitemid 38133769)
17. EA Azen NT Shahidi 1977 Androgen dependency in acquired aplastic anemia Am J Med 63 320 324 1:STN:280:DyaE2s3jvFGksA%3D%3D 10.1016/0002-9343(77)90249-2 578075 (Pubitemid 8160354)
18. K Shimoda K Shide K Kamezaki T Okamura N Harada N Kinukawa K Ohyashiki Y Niho H Mizoguchi M Omine M Ozawa M Haradaa 2007 The effect of anabolic steroids on anemia in myelofibrosis with myeloid metaplasia: retrospective analysis of 39 patients in Japan Int J Hematol 85 338 343 1:CAS:528:DC%2BD2sXntFOrsr4%3D 10.1532/IJH97.06135 17483079 (Pubitemid 47182062)
19. PJ Snyder H Peachey JA Berlin P Hannoush G Haddad A Dlewati J Santanna L Loh DA Lenrow JH Holmes SC Kapoor LE Atkinson BL Strom 2000 Effects of testosterone replacement in hypogonadal men J Clin Endocrinol Metab 85 2670 2677 1:CAS:528:DC%2BD3cXnslaiu7w%3D 10.1210/jc.85.8.2670 10946864 (Pubitemid 32269134)
20. C Leberbauer F Boulme G Unfried J Huber H Beug EW Mullner 2005 Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors Blood 105 85 94 1:CAS:528: DC%2BD2MXis1GktQ%3D%3D 10.1182/blood-2004-03-1002 15358620 (Pubitemid 40053068)
21. W Fried O Jonasson G Lang F Schwartz 1973 The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses Ann Intern Med 79 823 827 1:STN:280:DyaE2c%2FltFOltQ%3D%3D 4761909
22. SH Ballal DT Domoto DC Polack P Marciulonis KJ Martin 1991 Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease Am J Kidney Dis 17 29 33 1:STN:280:DyaK3M%2Fps1Oqtw%3D%3D 1986567
23. MA Woody LA Welniak R Sun ZG Tian M Henry S Richards A Raziuddin DL Longo WJ Murphy 1999 Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine Exp Hematol 27 811 816 1:CAS:528:DyaK1MXjslWhsbk%3D 10.1016/S0301-472X(99)00019-3 10340396 (Pubitemid 29231018)
24. SM Richards WJ Murphy 2000 Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function J Neuroimmunol 109 56 62 1:CAS:528:DC%2BD3cXmtVCku7k%3D 10.1016/S0165-5728(00)00303-9 10969182